RICT 2018
4 – 6 July, 2018
Strasbourg, France
ENYO Pharma is proud to announce that a Poster made with Inventiva and Rachel Nechushtai from Hebrew University of Jerusalem will be presented at the 54th edition of the International Conference on Medicinal Chemistry (RICT 2018) in Strasbourg, France on July 4-6, 2018.
RICT will focus on “Interfacing Chemical Biology and Drug Discovery”. The 3-day international congress offers the opportunity to ENYO Pharma to present a novel virus-inspired approach to discover first-in-class preclinical assets for a wide range of therapeutic areas. (www.rict2018.org)
Poster RICT 2018
Read next in 'Events'
- The 2024 international workshop on Alport syndrome
- ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
- 6th CKD Summit – Chronic Kidney Disease Drug Development
- ASN Kidney Week
- Alport Connect 2023, the annual Alport syndrome patient and family meeting in US